CDIO
$2.30-0.11 (-4.56%)
Cardio Diagnostics Holdings, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targe...
Recent News
Is DXC (DXC) Centralizing Digital And AI Leadership To Reframe Its Long-Term Competitiveness Story?
Earlier this month, DXC Technology appointed longtime executive Russell Jukes as its first Chief Digital Information Officer, giving him responsibility for leading the company’s end-to-end digital and AI agenda and internal technology environment. The move centralizes DXC’s digital, data, and AI efforts under a single leader, signaling a clearer push to embed AI across its services, operations, and workforce capabilities. Next, we’ll examine how consolidating DXC’s digital and AI leadership...
e.l.f. Beauty’s CDIO says she’s responsible for AI’s foundation, but that these tools aren’t an IT mandate
Ekta Chopra, the chief digital information officer of e.l.f. Beauty, acts as a champion of generative AI and helps make it pervasive across the company with AI tools that can assist employees with research inquiries, IT requests, and data analytics.
Cardio Diagnostics Holdings Second Quarter 2025 Earnings: US$0.97 loss per share (vs US$1.71 loss in 2Q 2024)
NasdaqCM:CDIO 1 Year Share Price vs Fair Value Explore Cardio Diagnostics Holdings's Fair Values from the Community and...
Cardio Diagnostics Holdings, Inc. (CDIO): A Bull Case Theory
We came across a bullish thesis on Cardio Diagnostics Holdings, Inc.(CDIO) on Stock Pursuit’s Substack. In this article, we will summarize the bulls’ thesis on CDIO. Cardio Diagnostics Holdings, Inc. (CDIO)’s share was trading at $4.4 as of 3rd June according to Yahoo Finance. Cardio Diagnostics (CDIO), currently trading below net cash with no long-term debt and […]
Cardio Diagnostics Holdings First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Cardio Diagnostics Holdings ( NASDAQ:CDIO ) First Quarter 2025 Results Key Financial Results Net loss: US$1.64m (loss...